Pharma CEOs consider job cuts and reducing hiring in 2024
By Kim, Jin-Gu | translator Kim, Jung-Ju
24.01.04 05:50:52
°¡³ª´Ù¶ó
0
[New Year¡¯s Feature] Pharmaceutical and Bio Industry CEO Survey ¨ê Employment Plans for 2024
Response that they will ¡®increase hiring falls from 15% last year to 9% this year¡¦plans to ¡¯reduce hiring rose from 11% to 13%
Of the 53 Pharma and Bio CEOs that responded to the survey, 2 responded that they ¡®plan to reduce workforce,¡¯ and 4 responded that ¡®the option is under review¡¯
13% of pharmaceutical and bio company CEOs have announced plans to reduce employment this year. Apart from this, another 12% have indicated the possibility of reducing their workforce this year.
Overall, the industry held a more cautious stance toward hiring this year. Compared to last year, the number of respondents who responded that they will increase hiring decreased, while the number of CEOs who plan to decrease employment has increased. Such figures suggest that the prolonged economic recession has deepened CEOs' concerns about hiring.
Pharma CEOs more cautious about ¡®expanding employment¡¯¡¦...15% last year¡æ9% this year
According to Dailypharm's 202
Kim, Jin-Gu(1000@dailypharm.com)
If you want to see the full article, please JOIN US (click)